You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Angiotensin-Converting Enzyme Inhibitors (ACEIs)

Showing 1 - 25 of 7,306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pathophysiologic Hemodynamics After Primary Unilateral Total Hip

Recruiting
  • Orthostatic Intolerance
  • Orthostatic Hypotension
  • Mobilisation procedure
  • Copenhagen, Denmark
    Hvidovre University Hospital
Apr 8, 2021

Angiotensin Converting Enzyme Inhibitors and Angiotensin

Not yet recruiting
  • COVID-19 Pneumonia
  • Covid_19
  • (no location specified)
Jun 5, 2022

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

Tranexamic Acid for Angiotensin-converting Enzyme

Completed
  • Angioedema
    • Dallas, Texas
      Methodist Dallas Medical Center
    Oct 17, 2023

    Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal

    Recruiting
    • Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
    • High ACE Activity Fresh Frozen Plasma
    • Normal Saline
    • Saint Louis, Missouri
      Barnes-Jewish Hospital
    Oct 24, 2022

    Angiotensin Converting Enzyme rs Gene Polymorphism and

    Recruiting
    • Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
    • DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD
    • Sohag, Egypt
      Sohag university Hospital
    Sep 20, 2023

    Bradykinin-degradating Enzymes Activities in

    Recruiting
    • Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
    • Assay of Bradykinin-degradating enzymes.
    • Grenoble, France
      Chu Grenoble Alpes
    Jan 14, 2022

    Angiotensin Converting Enzyme in Systemic Lupus Erythematous

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Angiotensin Converting Enzyme test
    • Sohag, Egypt
      Sohag University Hospital
    Aug 24, 2022

    Precision Treatment With Angiotensin Converting Enzyme Inhibitor

    Recruiting
    • Hypertension
    • +2 more
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Sep 7, 2022

      Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)

      Recruiting
      • Surgery
      • +2 more
      • Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
      • +4 more
      • Amsterdam, Netherlands
      • +6 more
      Jan 6, 2022

      COVID Trial in Tanta (ACEIs, Conventional treatment)

      Not yet recruiting
      • COVID
      • ACEIs
      • Conventional treatment
      • Tanta, Egypt
        Tanta University
      Apr 11, 2020

      Vascular Access Complication Trial in Rawalpindi (Losartan Potassium, multi-vitamins)

      Recruiting
      • Vascular Access Complication
      • Rawalpindi, Punjab, Pakistan
        Anas Bin Saif
      Nov 22, 2021

      AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)

      Recruiting
      • AML
      • Acute Myeloid Leukemia
      • Charlottesville, Virginia
        University of Virginia
      Jul 2, 2022

      Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Co-Enzyme Q10
      • (no location specified)
      Jul 4, 2023

      Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi

      Active, not recruiting
      • Chronic Kidney Disease
      • +3 more
      • Continuation of ACEi and/or ARBs
      • San Francisco, California
        University of California, San Francisco
      Oct 4, 2021

      Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Vitamin K 2
      • (no location specified)
      Jul 4, 2023

      Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin

      Completed
      Has Results
      • Hypertension
      • COVID-19
      • Angiotensin converting enzyme inhibitor
      • +2 more
      • Kiev, Please Select, Ukraine
        Medical Practice Prof D.Ivanov
      Feb 16, 2022

      Covid19 Trial in Vienna (Angiotensin Converting Enzyme 2, Sodium chloride)

      Completed
      • Covid19
      • Angiotensin Converting Enzyme 2
      • Sodium chloride
      • Vienna, Austria
        Medical University of Vienna
      Sep 22, 2022

      Angiotensin Converting Enzyme, Brain, Gut Dysbiosis in Pulmonary

      Active, not recruiting
      • Pulmonary Arterial Hypertension
        • Jacksonville, Florida
        • +1 more
        Jan 10, 2022

        COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

        Recruiting
        • COVID-19
        • Cardiovascular Diseases
        • Angiotensin converting enzyme inhibitor
        • Angiotensin II Receptor Blockers
        • Maceio, Alagoas, Brazil
        • +30 more
        Jan 13, 2023

        COVID 19 Trial in Secaucus (HLX71, Placebo)

        Completed
        • COVID 19
        • Secaucus, New Jersey
          Frontage Clinical Services, Inc.
        Mar 20, 2022

        Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)

        Completed
        Has Results
        • Type 2 Diabetes Mellitus
        • Hypertension
        • Placebo
        • +3 more
        • Nashville, Tennessee
          Vanderbilt University
        Feb 8, 2022

        Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

        Not yet recruiting
        • Diabetic Nephropathy Type 2
        • Empagliflozin 25 MG
        • Enalapril Maleate 20 mg
        • (no location specified)
        May 9, 2022

        Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

        Recruiting
        • Kidney Disease
        • Chula Vista, California
        • +5 more
        Jan 23, 2023

        Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

        Recruiting
        • Diabetic Kidney Disease
        • Liverpool, New South Wales, Australia
        • +6 more
        May 17, 2022